Get the Stockscreener App
2.14
4.68%
-0.105
Aclarion Inc stock is traded at $2.14, with a volume of 21,361.
It is down -4.68% in the last 24 hours and down -17.05% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
See More
Previous Close:
$2.245
Open:
$2.25
24h Volume:
21,361
Relative Volume:
1.05
Market Cap:
$6.17M
Revenue:
$77,900
Net Income/Loss:
$-8.05M
P/E Ratio:
-0.2319
EPS:
-9.2296
Net Cash Flow:
$-7.47M
1W Performance:
-8.94%
1M Performance:
-17.05%
6M Performance:
-32.49%
1Y Performance:
-76.09%
1-Day Range:
$0.00
$0.00
1-Week Range:
$2.0909
$2.41
52-Week Range:
$1.95
$12.03
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON vs VEEV, BTSG, TEM, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
2.14 | 6.17M | 77,900 | -8.05M | -7.47M | -9.2296 |
VEEV
Veeva Systems Inc
|
301.63 | 48.84B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
62.65 | 12.40B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
68.22 | 12.39B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
105.14 | 8.48B | 646.34M | -512.40M | 202.76M | -6.6871 |
HQY
Healthequity Inc
|
90.19 | 7.46B | 1.34B | 230.70M | 440.96M | 2.6695 |
Aclarion Inc Stock (ACON) Latest News
Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment - GlobeNewswire Inc.
ACON Q2 2026 Earnings: Wider -$1.12 Per-Share Loss Sends Shares Down 4.76%Negative Surprise Momentum - vinanet.vn
Aclarion Inc. (ACON) Slips 4.76% to $2.4 as Key Support Level Comes into FocusSweep Order Flow - dars.gov.et
Aclarion Inc (ACONW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Aclarion (ACONW) Stock: Holds Near $0.03 in the Latest Reading; Chart View - vinanet.vn
Aclarion (ACON) Outlook: Moves 0.74% Higher to $2.71 on the Day; Price Setup: Traders Can Monitor the $2.57-$2.85 Range in Latest TradingIndex Put Call - vinanet.vn
Aclarion (ACON) Upgraded to Buy: Here's Why - Eastern Progress
Aclarion, Inc. Revenue Breakdown – NASDAQ:ACON - TradingView
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Orthopedics This Week
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site - Ortho Spine News
AclarionAnticipates Having Initial Interna - Moomoo
Aclarion adds University of Arizona to Nociscan spine trial By Investing.com - Investing.com Australia
Aclarion adds University of Arizona to Nociscan spine trial - Investing.com
Aclarion Announces Addition of University of Arizona College of MedicinePhoenix as CLARITY Trial Site - The Manila Times
Aclarion's 300-patient back-pain study now has 10 enrolling sites - Stock Titan
Aclarion (ACON) EPS and Revenue: The Available Earnings Metric Delivers a Miss in Latest Trading; After Results: The Stock Gains 6.54% on the DayROIC Trend Report - vinanet.vn
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com Canada
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com India
Aclarion director Amanda Williams buys $15,989 in common stock By Investing.com - Investing.com UK
Aclarion director Amanda Williams buys $15,989 in common stock - Investing.com
Canadian (CP): Records a 0.81% Increase to $94.44 in Latest Trading; Range View: the $89.72 to $99.16 Range Remains in Focus in the Latest ReadingRVOL Spike - careplusvn.com
Top Aclarion Executive Makes Bold Insider Move on Company Stock - TipRanks
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Nigeria
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayHealthcare Earnings Report - vinanet.vn
ACON | Aclarion, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com India
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com Canada
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock By Investing.com - Investing.com UK
Aclarion CFO Gregory Gould buys $24,500 of Aclarion stock - Investing.com
Major Insider Buying Spree Signals Strong Confidence in This Tech Stock - TipRanks
Aclarion (ACON) Earnings Numbers in Focus: EPS Comes in Below Forecast under the Current Snapshot; Investor Response: The Market Price Declines 6.14% on the DayEarnings Beat Streak - dars.gov.et
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Nigeria
Aclarion director David K. Neal buys $18,000 in common stock By Investing.com - Investing.com Nigeria
Aclarion director Ryan Bond buys $50,059 in ACON shares By Investing.com - Investing.com Nigeria
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com Canada
Aclarion director David K. Neal buys $18,000 in common stock - Investing.com
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com India
Aclarion director William Wesemann buys $5,031 in company stock By Investing.com - Investing.com UK
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion (ACON) director lifts stake to 23,713 shares - Stock Titan
Aclarion director William Wesemann buys $5,031 in company stock - Investing.com
Aclarion CEO Brent Ness buys $12,090 in company stock - Investing.com
Aclarion director Ryan Bond buys $50,059 in ACON shares - Investing.com
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeNarrow Range Breakout - dars.gov.et
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeRounding Bottom - dars.gov.et
Aclarion Inc. Warrant (ACONW) Jumps 21.95% to $0.03 as Support and Resistance ConvergeFactor Valuation - dars.gov.et
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Aclarion Inc Stock (ACON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Gould Gregory A | CFO |
Aug 14 '26 |
Buy |
2.45 |
10,000 |
24,500 |
60,000 |
| Bond Ryan | Director |
Aug 13 '26 |
Buy |
2.37 |
21,122 |
50,059 |
76,122 |
| Wesemann William | Director |
Aug 13 '26 |
Buy |
2.34 |
2,150 |
5,031 |
23,713 |
| Neal David K | Director |
Aug 13 '26 |
Buy |
2.40 |
7,500 |
18,000 |
30,002 |
| Ness Brent | Chief Executive Officer |
Aug 13 '26 |
Buy |
2.31 |
5,234 |
12,091 |
111,534 |
| Breidbart Scott | Director |
May 12 '26 |
Buy |
3.18 |
5,664 |
18,012 |
5,664 |
| Neal David K | Director |
May 11 '26 |
Buy |
3.10 |
2,500 |
7,750 |
2,502 |
| Ness Brent | Chief Executive Officer |
May 11 '26 |
Buy |
3.18 |
6,289 |
19,999 |
6,300 |
| Wesemann William | Director |
May 06 '26 |
Buy |
3.30 |
1,562 |
5,155 |
1,563 |
| Ness Brent | Chief Executive Officer |
Nov 26 '25 |
Buy |
6.20 |
10 |
62 |
11 |
3.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):